The Slc30a8 gene encodes the islet-specific zinc transporter ZnT-8, which provides zinc for insulin-hexamer formation. Polymorphic variants in amino acid residue 325 of human ZnT-8 are associated with altered susceptibility to Type 2 diabetes and ZnT-8 autoantibody epitope specificity changes in Type 1 diabetes. To assess the physiological importance of ZnT-8, mice carrying a Slc30a8 exon 3 deletion were analysed histologically and phenotyped for energy metabolism and pancreatic hormone secretion. No gross anatomical or behavioural changes or differences in body weight were observed between wild-type and ZnT-8 −/− mice, and ZnT-8 −/− mouse islets were indistinguishable from wild-type in terms of their numbers, size and cellular composition. However, total zinc content was markedly reduced in ZnT-8 −/− mouse islets, as evaluated both by Timm's histochemical staining of pancreatic sections and direct measurements in isolated islets. Blood glucose levels were unchanged in 16-week-old, 6 h fasted animals of either gender; however, plasma insulin concentrations were reduced in both female (∼ 31 %) and male (∼ 47 %) ZnT-8 −/− mice. Intraperitoneal glucose tolerance tests demonstrated no impairment in glucose clearance in male ZnT-8 −/− mice, but glucose-stimulated insulin secretion from isolated islets was reduced ∼ 33 % relative to wild-type littermates. In summary, Slc30a8 gene deletion is accompanied by a modest impairment in insulin secretion without major alterations in glucose metabolism.
INTRODUCTION
Zinc homoeostasis is maintained by two types of proteins, namely metallothioneins and zinc transporters [1] , the former being involved in the intracellular trafficking and storage of zinc. There are two classes of zinc transporters, the SLC39 (Zip) family that controls the cellular uptake of zinc and the SLC30 (ZnT) family that controls zinc efflux into the extracellular matrix and intracellular vesicles [1] . In mammalian cells the ZnT family comprises ten members that share a similar six transmembrane domain structure with a histidine-rich loop located between helices IV and V, with the exception of ZnT-6 which contains a serine-rich loop and ZnT-10 which contains a basic amino-acid rich loop [1] .
Chimienti et al. [2] had suggested that expression of the Slc30a8 gene, which encodes the zinc transporter ZnT-8, is restricted to pancreatic islets, specifically insulin-secreting β-cells, but recent data suggest that it is also expressed in glucagon-secreting α-cells [3] . Recent GWA (genome-wide association) studies have shown that sequence variations in SLC30A8 are linked to an increased susceptibility to the development of Type 2 diabetes [4] [5] [6] [7] . ZnT-8 has also recently been identified as an autoantigen in Type 1 diabetes in humans [8] . Interestingly, the same polymorphic variant in amino acid residue 325 of human ZnT-8 that is associated with altered susceptibility to Type 2 diabetes also affects ZnT-8 autoantibody epitope specificity in Type 1 diabetes [9] . Within β-cells ZnT-8 localizes to insulin secretory granules [10] and because insulin is stored as a hexamer bound to two zinc ions, it has been proposed that ZnT-8 is important for providing zinc to allow for the proper maturation, storage and secretion of insulin [11] . In the present study we examine the effect of a global Slc30a8-null mutation in vivo, a mouse model that is directly relevant to Type 2 diabetes susceptibility in humans. The results are consistent with a role for ZnT-8 in islet function, although surprisingly not in whole-body glucose metabolism.
MATERIALS AND METHODS
For details on the generation of the Slc30a8-targeting vector, generation and PCR genotyping of Slc30a8-knockout mice and the analysis of islet number, size and cellular composition in Slc30a8-knockout mice please see Supplementary Materials and methods (at http://www.BiochemJ.org/bj/421/bj4210371add.htm).
Animal care
The animal housing and surgical facilities used for the mice in these studies meet the American Association for the Accreditation of Laboratory Animal Care standards. All animal protocols were approved by the Vanderbilt University Medical Center Animal Care and Use Committee. Mice were maintained on standard rodent chow (LabDiet 5001; 23 % protein and 4.5 % fat; PMI Nutrition International) with food and water provided ad libitum.
Breeding strategy for Slc30a8-knockout mice F1 chimaeric (129SvEv Brd × C57BL/6J) mice were interbred to generate F2 wild-type, heterozygous and homozygous knockout mice. The F2 heterozygous mice were then bred with F1
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hybrid (C57BL/6J × 129SvEv Brd ) mice. Two male and two female heterozygous mice from this breeding, along with their heterozygous offspring, were then interbred to generate a mouse colony used in the phenotypic characterization of the effect of the Slc30a8-null mutation.
Immunohistochemical staining
Pancreas tissue was fixed for 1 h in 4 % (w/v) paraformaldehyde in PBS and embedded for paraffin sectioning (8 μm) . Primary antisera against insulin (guinea-pig 1:100; Dako), glucagon (mouse 1:100; Sigma) and somatostatin (rat 1:100; Abcam) were combined with a rabbit polyclonal antibody raised against a 102 amino acid C-terminal human ZnT-8 peptide (amino acids 268-369; used at 1:500) and were detected with speciesspecific secondary antibodies conjugated to Cy2 (carbocyanine), Cy3 (indocarbocyanine), Cy5 (indodicarbocyanine) and AMCA (aminomethylcoumarin) (all from Jackson Immunoresearch Laboratories).
Timm's staining analyses in Slc30a8-knockout mice The determination of zinc content in wild-type and Slc30a8-knockout mouse pancreas was based on further modification of the revised Timm's protocol described by Danscher et al. [12] . Briefly, pancreatic tissue sections (8 μm; frozen and paraffin) fixed in 4 % (w/v) paraformaldehyde were placed on glass slides and immersed in 0.1 % sodium sulfide in 0.15 M sodium phosphate buffer (pH 7.4) for 1 h in glass jars inside a chemical fume hood. The slides were briefly rinsed in PBS and immersed in AMG (autometallography) developer [pH 3.8; 60 ml of gum arabic, 10 ml of sodium citrate (25.5 g of citric acid monohydrate+23.5 g of sodium citrate dihydrate in 100 ml of de-ionized water), 15 ml of reducing agent (0.056 % hydroquinone in de-ionized water at 40
• C) and 15 ml of solution containing silver ions (0.008 % silver lactate in de-ionized water at 40
• C) added just before use]. All glassware used for AMG development was rinsed in Farmer's solution (10 % sodium thiosulfate/10 % potassium ferricyanide; 9:1) and warm water. AMG development was carried out at room temperature (22 • C), in the dark and with gentle shaking. The reaction was stopped after 45 min with 5 % sodium thiosulfate solution for 10 min. The slides were rinsed in warm water several times, counterstained with haematoxylin and eosin and permanently mounted.
Measurement of islet zinc content
Freshly isolated islets from wild-type and Slc30a8-knockout mice were washed in Ca 2+ -free Hank's balanced salt solution and frozen down at − 80
• C in 20 islet aliquots. Islet pellets were lysed by re-suspension in 1 ml of lysis buffer [1 % Triton X-100 in 10 mM Tris/HCl (pH 7.4)]. The Zn 2+ concentration in the lysate was measured using the Zn 2+ -sensitive fluorescent dye FluoZin-3 (Invitrogen). In the presence of 1.181 μM FluoZin-3 the fluorescent signal at the emission peak (516 nm) was measured in the total sample lysate using a fluorometer (PTI Instruments). The fluorescent signal was compared with a standard curve generated from serial dilutions of ZnSO 4 in lysis buffer to obtain the lysate Zn 2+ concentration and thus the Zn 2+ content per islet. As a normalization factor, the protein content per islet was measured in the total sample lysate using the BCA (bicinchoninic acid) protein assay (Pierce). To minimize contaminating Zn 2+ , all solutions were made in double-distilled water (18.2 M ), avoiding the use of any glassware. Blank samples were also prepared during the islet isolation to quantify any additional Zn 2+ contamination.
Phenotypic analysis of Slc30a8-knockout mice
Animals were fasted for 5 h, weighed and then 1 h later anaesthetized using isoflurane before collection of blood samples (∼ 200 μl) from the retro-orbital venous plexus. Whole-blood glucose concentrations were determined using an Accu-Check Advantage monitor (Roche). EDTA (5 μl; 0.5 M) was then added before centrifugation (16 000 g for 10 min at 4
• C) to isolate plasma. Trasylol (aprotinin; 5 μl; Bayer Health Care) was added to the plasma to prevent proteolysis of glucagon. Cholesterol was assayed using the cholesterol reagent kit (Raichem), whereas triacylglycerol and glycerol were assayed using a serum triacylglycerol determination kit (Sigma). Insulin and glucagon levels were quantified using radioimmunoassays by the Vanderbilt Diabetes Center Hormone Assay Core.
Intraperitoneal glucose tolerance tests on overnight fasted conscious mice were performed as previously described [13] .
Islet isolation and GSIS (glucose-stimulated insulin secretion) assays
Islets were isolated from ∼ 5-month-old male mice as described previously [14] . After isolation, islets were rinsed in three 12 ml changes of RPMI-1640 medium containing 10 % (v/v) FBS (foetal bovine serum), 100 units/ml penicillin, 100 μg/ml streptomycin and 11 mM glucose, and then cultured in 10 cm non-treated plates overnight at 37
• C. The next day islets were transferred into medium with 5 mM glucose and allowed to equilibrate for 1 h at 37
• C. Following the equilibration period, 50 IEQs (islet equivalents) were incubated in 5 ml of RPMI-1640 medium with 5 or 11 mM glucose for 30 min at 37
• C. At the end of the static incubations, islets were collected into 1.5 ml tubes, washed three times with 1 ml of 1 × PBS and insulin was extracted in 0.2 ml of acid alcohol for 48 h at 4
• C. The medium from the static incubations was harvested into 15 ml conical tubes and centrifuged at 600 g for 1 min at 4
• C. Islet insulin extracts and static incubation medium were stored at − 80
• C until assayed for insulin by radioimmunoassay.
Statistical analyses
Data were analysed using a Student's t test: two sample assuming equal variance. The level of significance was as indicated (twosided test).
RESULTS

Biochemical characterization of ZnT-8 −/− mice
The human and mouse ZnT-8 genes contain eight exons ( [2] and results not shown). A modified mouse Slc30a8 allele, in which 135/147 bp of exon 3 and the first 10 bp of intron 3 were replaced by a LacZ/Neo cassette, was generated by homologous recombination in 129/SvEv Brd (Lex-2) ES (embryonic stem) cells ( Figure 1A ). Deletion of exon 3 disrupts two putative ZnT-8 transmembrane domains [2] . Correct gene targeting was confirmed by Southern blot ( Figure 1B ) and PCR (results not shown) analysis prior to injection of ES cells into C57BL/6 (albino) blastocysts and subsequent generation of ZnT-8 −/+ mice on a mixed 129/SvEv
Brd × C57BL/6 background. To confirm that the targeting strategy had abolished ZnT-8 expression, immunohistochemical staining was performed on pancreas sections prepared from a ZnT-8 −/− mouse and a wildtype littermate. The size and number of islets in ZnT-8 −/− animals were indistinguishable from wild-type littermates, as were the relative numbers of α-and β-cells (Supplementary Figure S1 at http://www.BiochemJ.org/bj/421/bj4210371add.htm). Histological analysis of zinc content on frozen pancreatic sections using a modified Timm's staining procedure that involves silver enhancement of metal sulfide precipitation showed that, in wildtype mouse pancreas, islets contained abundant zinc relative to the exocrine tissue (Figure 2A ). This contrasted with ZnT-8 −/− mouse pancreas in which no difference was observed in Timm's staining between islets and exocrine tissue, although gross islet morphology was preserved (Figure 2A ). These results are consistent with analyses of zinc content in isolated islets using an assay that detects free and loosely bound zinc ( Figure 2B ). Figure 2 (B) shows that zinc content was markedly reduced in islets isolated from Slc30a8-knockout mice relative to those isolated from wild-type mice. The concentration of zinc detected in wildtype islets was similar to that previously reported in the isletderived INS1 cell line [10] . −/− mice were indistinguishable from their wild-type and heterozygous littermates at all ages, from birth up to 1 year in age. No gross anatomical changes were observed either externally or to major internal organs, and no differences were seen in the weights or lengths of ZnT-8 −/− compared with wild-type mice (Table 1) . Table 1 summarizes metabolic parameters in these animals assayed at 16 weeks of age following a 6 h fast. No marked changes in plasma cholesterol, triacylglycerol or glycerol were observed in either male or female ZnT-8 −/− mice relative to wild-type animals ( Table 1 ). Blood glucose and glucagon concentrations were also unchanged in both male and female ZnT-8 −/− mice relative to wild-type animals; however, a statistically significant difference in plasma insulin concentrations was observed (Table 1 ). This result suggests that, although the absence of ZnT-8 might affect islet function, it has a limited effect on whole-body glucose metabolism. In addition, since a statistically significant difference in plasma insulin concentrations was not observed between male or female ZnT-8 −/+ mice relative to wild-type animals, this suggests that loss of a single Slc30a8 allele is insufficient to affect islet function (Table 1) mice showed gender-related variation in the majority of these metabolic parameters that were in the same direction and of similar magnitude to the gender-related differences in wild-type mice. Thus in males compared with females, insulin, triacylglycerols, cholesterol and glucose were all higher, whereas glucagon was lower (Table 1) .
Since some metabolic disturbances only become readily apparent under stimulatory rather than basal conditions intraperitoneal glucose tolerance tests were used to provide a measurement of dynamic islet function in vivo. Following glucose injection (2 g/kg of body weight) blood glucose was assessed over a 120 min period (Figure 3) . The data show no impairment in glucose clearance between wild-type and ZnT-8 −/− mice ( Figure 3 ). This result again suggests that, although the absence of ZnT-8 might affect islet function it has a limited impact on whole-body glucose metabolism, at least under the conditions examined.
Insulin secretion from ZnT-8 −/− mouse islets
To directly assess the impact of ZnT-8 on islet function, GSIS was compared in islets isolated from male wild-type and ZnT-8 −/− mice in static incubations. Figure 4 (A) shows that insulin content did not differ between wild-type and ZnT-8 −/− mouse islets, whereas Figure 4 (B) shows that GSIS from ZnT-8 −/− mouse islets was reduced ∼ 33 % relative to that from wild-type mouse islets.
DISCUSSION
In the present study we examine the effect of a global Slc30a8-null mutation in vivo, a mouse model that is directly relevant to Type 2 diabetes susceptibility in humans. The study addresses the hypothesis, based on GWA data, that changes in the activity or stability of the ZnT-8 protein may result in islet dysfunction, which contributes to the pathogenesis of Type 2 diabetes. The results indicate that deletion of the Slc30a8 gene results in a mild metabolic phenotype on a mixed 129SvEv
Brd × C57BL/6 background. Plasma insulin is reduced in both male and female ZnT-8 −/− mice following a 6 h fast (Table 1) . Consistent with this observation, GSIS from isolated islets is impaired (Figure 4 ) and
Figure 4 Analysis of insulin content and GSIS in isolated ZnT-8 −/− mouse islets
Islets were isolated from wild-type (WT) and ZnT-8 knockout (KO) mice and then insulin content (A) and GSIS (B) were assayed as described in the Materials and methods section. Results are the means + − S.E.M. from three to four islet preparations. *P < 0.05 compared with wild-type 11 mM glucose.
islet zinc content is markedly reduced (Figure 2) , although islet size, number and cellular composition are unaffected (Supplementary Figure S1 ). These observations in ZnT-8 −/− mice are consistent with the demonstration that overexpression of ZnT-8 in INS-1 cells has the opposite effect, stimulating zinc accumulation and GSIS [10] . Although the loss of ZnT-8 function only has a mild effect presumably accounts for the small contribution of Slc30a8 mutations to Type 2 diabetes, as reflected in the odds ratio of 1.12 [4] [5] [6] [7] . Future studies will be designed to examine whether the absence of ZnT-8 affects glucose metabolism under conditions more favourable for the development of glucose intolerance, such as following high-fat feeding or in older animals.
Although the results indicate that ZnT-8 is important for normal islet function, surprisingly whole-body glucose metabolism appears unaltered based on an assessment of fasting glucose levels (Table 1 ) and glucose tolerance tests (Figure 3 ). These observations suggest that ZnT-8 is not necessary for glucose homoeostasis, at least under the conditions examined. There appear to be two possible explanations for the decrease in plasma insulin without a concomitant increase in blood glucose (Table 1) . There is a statistically significant decrease in plasma glucagon (∼ 20 %) between male ZnT-8 −/+ and ZnT-8 −/− mice, although not between ZnT-8 +/+ and ZnT-8 −/− mice (Table 1) . If the latter simply reflects a lack of power to detect a small change in plasma glucagon, the former would imply that glucagon secretion is also impaired in male ZnT-8 −/− mice. In this event an offsetting decrease in both insulin and glucagon secretion could result in normal blood glucose. Indeed, the insulin/glucagon ratios in individual animals were not statistically different between male wild-type and ZnT-8 −/− mice (results not shown). Future experiments studying glucagon secretion from isolated islets will address this possibility. In contrast, in female mice there are no statistically significant differences in glucagon levels between groups (Table 1) . This suggests that there may be differences in insulin sensitivity between female wild-type and ZnT-8 −/− mice. This would be consistent with the results of post-hoc QUICKI calculations [15] suggesting a statistically significant difference in insulin sensitivity between female wild-type and ZnT-8 −/− mice (results not shown). Such a difference could have arisen as an adaptive change during development to compensate for low plasma insulin. Alternatively, a difference in insulin sensitivity could arise if ZnT-8 were expressed in other tissues, specifically ones which directly or indirectly modulate insulindependent glucose disposal. Interestingly, Murgia et al. [16] have recently demonstrated that ZnT-8 is expressed at low levels in tissues other than islets. Future experiments will directly compare insulin sensitivity in female wild-type and ZnT-8 −/− mice using hyperinsulinaemic clamps. Finally, zinc is required not only for stabilizing the insulin crystal within the insulin storage granule, but may also be essential for the conversion of proinsulin into insulin [17] . Increased circulating pro-insulin is a feature of early Type 2 diabetes and impaired glucose tolerance [18, 19] and in a group genetically at risk of developing Type 2 diabetes, the SLC30A8 allele was associated with reduced proinsulin into insulin conversion, although not insulin secretion [20] . Since pro-insulin has only ∼ 3 % of the potency of insulin [21] , if pro-insulin secretion was markedly increased in the female ZnT-8-knockout mice this could also explain the reduced plasma insulin levels associated with unchanged blood glucose levels. Unfortunately, commercially available assays for murine proinsulin are unavailable at the current time.
Chimienti et al. [2] had previously reported that ZnT-8 is only expressed in pancreatic islet β-cells, but using antiserum raised against a 102-amino-acid C-terminal human ZnT-8 peptide (amino acids 268-369) we found that ZnT-8 is also clearly expressed in α-cells ( Figure 1C ). This observation is consistent with the results of Gyulkhandanyan et al. [3] who examined ZnT-8 expression in dispersed islet cells. The specificity of our antiserum was confirmed by the absence of staining in sections prepared from ZnT-8 −/− mouse pancreas ( Figure 1C ). The hypothesis that glucagon secretion may be impaired in male ZnT-8 −/− mice would therefore be consistent with the expression of ZnT-8 in α-cells ( Figure 1C) . However, the possibility also exists that glucagon secretion from α-cells has been indirectly affected by the absence of ZnT-8 in β-cells. Indeed, although the mechanism(s) involved are disputed, zinc release from β-cells inhibits glucagon secretion from α-cells [3, 22, 23] .
The SNP (single nucleotide polymorphism) that linked the human SLC30A8 gene to increased Type 2 diabetes susceptibility [4] [5] [6] [7] is located in the C-terminus of ZnT-8 and represents a nonsynonymous polymorphism that changes the sequence of amino acid residue 325 [2] . In theory this ZnT-8 variant could represent either a gain-or loss-of-function, but because overexpression of ZnT-8 enhances GSIS [10] and because deletion of the Slc30a8 gene in mice impairs GSIS (Figure 4) we would predict that this human sequence variant impairs ZnT-8 function. Future experiments will address this hypothesis.
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MATERIALS AND METHODS
Generation of the Slc30a8-targeting vector
The ZnT-8 mutant mice were generated and analysed in collaboration with Lexicon Pharmaceuticals. An Slc30a8-targeting vector was derived using the Lambda KOS system [1] . The Lambda KOS phage library, arrayed into 96 superpools, was screened by PCR using exon 3-specific primers (UTT047-1, 5 -GTGAGGATAGCCAGACTCC-3 and UTT047-2, 5 -CAG-CTAGTAATTCAGCACAAC-3 ). The PCR-positive phage superpools were plated and screened by filter hybridization using the 516 bp amplicon derived from primers UTT047-1 and UTT047-2 as a probe. A pKOS genomic clone, pKOS-36, was isolated from the library screen and the presence of the Slc30a8 gene was confirmed by sequence and restriction analysis. Genespecific arms (5 -GATATTGTGCATCTCACAGGTGGACACG-TTG-3 and 5 -CTATATCATTATGCATTCACTATTGCGCAAT-CAG-3 ) were appended by PCR to a yeast selection cassette containing the URA3 marker. The yeast selection cassette and pKOS-36 were co-transformed into yeast, and clones that had undergone homologous recombination were isolated. DNA sequencing confirmed that recombination had replaced a 145 bp region, from base pair 13 of exon 3 extending to the first 10 bp of the third intron, with the yeast selection cassette. To complete the Slc30a8-targeting vector, the yeast cassette was subsequently replaced with a selection cassette incorporating an IRES (internal ribosome entry site), the LacZ gene, the herpes simplex virus TK (thymidine kinase) promoter and a Neo (neomycin) selectable marker ( Figure 1A of the main paper). The expression of LacZ mRNA is driven by the ZnT-8 promoter with translation dependent on the IRES, whereas expression of Neo mRNA is driven by the TK promoter.
Generation of Slc30a8-knockout mice
The NotI-linearized targeting vector was electroporated into 129 SvEv Brd (Lex-2) ES cells. G418/FIAU-resistant ES cell clones were isolated, and correctly targeted clones were identified and confirmed by Southern blot analysis using a 354 bp 5 external probe (9/10), generated by PCR using wild-type Lex-2 ES cell genomic DNA as the template with primers (UTT047-9, 5 -GCTGCAGACTCTTCTCATATGTAG-3 and UTT047-10, 5 -CATCTGTAGGCATATAAGTGCATGC-3 ), and a 314 bp 3 internal probe (11/12) , amplified by PCR using primers (UTT047-11, 5 -CACAGTCCTCTAAACCCACAGAGTG-3 and UTT047-12, 5 -GATGACTACACAAAGGTGAAGAGTG-3 ). Southern blot analysis using probe 9/10 detected a 8.0 kbp wild-type band and 11.1 kbp mutant band in PstI-digested genomic DNA, whereas probe 11/12 detected a 7.6 kbp wild-type band and 12.8 kbp mutant band in NheI-digested genomic DNA. Correctly targeted clones were also confirmed by PCR using the primers indicated below. The primers represented sequences in: exon 3, primer 1, 5 -GTGAGGATAGCCAGACTCC-3 ; intron 2, primer 2, 5 -CAGCTAGTAATTCAGCACAAC-3 ; intron 3, primer 4, 5 -CCCACAATAACTGCATTGACC-3 ; and the Neo gene, Neo3a primer, 5 -GCAGCGCATCGCCTTCTATC-3 . Cells from the correctly targeted ES cell clone, designated 2H8 ( Figure 1B of the main paper), were microinjected into C57BL/6 (albino) blastocysts resulting in the generation of chimaeric mice.
PCR genotyping of Slc30a8-knockout mice
Mouse-tail DNA was genotyped using PCR in conjunction with primers that distinguished between the wild-type and targeted alleles. Primers A (5 -TGCGGCTCATCTCTTAATTG-3 ) and B (5 -CCTCGATGACAACCACAAAG-3 ) were used to amplify a 70 bp product from the wild-type allele whereas primers C (5 -TTTCCATATGGGGATTGGTG-3 ) and D (5 -CTGGAATTCCGCCGATACT-3 ) were used to amplify a 61 bp product from the targeted allele. Tail DNA was isolated and purified by standard procedures [2] . The wild-type and targeted allele fragments were amplified using 2.8 ng of genomic DNA and iQ SYBR Green Supermix (Bio-Rad) under the following reaction conditions: 94
• C for 30 s; 60 • C for 30 s; and 72
• C for 30 s (for 40 cycles). Standard-curve analyses were performed for each set of samples to determine the efficiencies of the two PCR reactions, which were both greater than 95 %.
Analysis of islet number, size and cellular composition in Slc30a8-knockout mice
At least ten islets from a single or 20th consecutive pancreatic section were examined and scored from all groups of mice (n = 6). Images of individual islets co-immunostained for insulin and glucagon were recorded with an Olympus BX51 microscope using a Pixera 600 digital colour camera and analysed with Image-Pro Plus software (Media Cybernetics). Briefly, the islet perimeter was marked with a pen tracer tool and Cy3 (indocarbocyanine)-stained glucagon-positive cells and Cy2 (carbocyanine)-stained insulin-positive cells with associated nuclei (stained by Hoechst 33258) were counted manually in a double-blind manner by two independent observers. Nuclei within the islet area that were not associated with either insulin-or glucagon-positive cells were designated non-α-/β-cells. Islet numbers and pancreatic area estimations were performed by scanning pancreatic sections immunostained for either insulin or glucagon using immunoperoxidase staining with diaminobenzidine as the pigment chromogen. The slides were counterstained with haematoxylin and scanned into ScanScope GL (Aperio). Using Imagescope viewing software (Aperio), total pancreatic and all individual islet areas (endocrine) visualized within the sections were quantified using a pen tracer tool. The percentage area was calculated as: 100×(the sum of all individual islet areas)/(total area of the pancreatic section) and averaged (n = 6 each group).
